Episodes of (Dis)Connected Consciousness in ICU Survivors
Launched by UNIVERSITY OF LIEGE · Jun 24, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This study is looking at patients who have spent at least a week in the intensive care unit (ICU) and experienced a period where they were unconscious, either because of medicine or other reasons. Researchers want to learn more about episodes where patients felt connected or disconnected from their surroundings during this time. This includes experiences like near-death experiences or feeling like they were outside their own body. The study also aims to find out what might increase the chances of having these experiences and how they affect patients’ mental health up to six months later.
If you are an adult who stayed in the ICU for seven days or more and went through a period of unconsciousness, you might be eligible to join, as long as you speak French and don’t have certain conditions like ongoing confusion, deafness, blindness, or difficulty speaking. Participants will be asked about their experiences during and after their ICU stay, and they will have a follow-up six months later to discuss how these experiences may have affected their wellbeing. This research is important because it helps doctors understand the mental and emotional effects of critical illness and recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients who survived a ≥7 days stay in the intensive care unit
- • Experienced a pharmacological or non-pharmacological episode of loss of consciousness
- • French speaking
- Exclusion Criteria:
- • Refusal
- • Chronic disorder of consciousness
- • Confusion or delirium
- • Deafness
- • Blindness
- • Aphasia
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liège, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported